Cargando…
P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430501/ http://dx.doi.org/10.1097/01.HS9.0000972080.35265.1c |
_version_ | 1785090979123953664 |
---|---|
author | Jiang, Erlie Chen, Shulian Zhang, Xiaoyu Zhai, Weihua Niu, Ting Xu, Yajing Gao, Guangxun Fan, Shengjin Zhou, Zeping Zhou, Fang Liu, LI Yang, Wei Liu, Qifa Zhang, XI Bai, Hai XI, Rui He, Yi Feng, Sizhou Han, Mingzhe |
author_facet | Jiang, Erlie Chen, Shulian Zhang, Xiaoyu Zhai, Weihua Niu, Ting Xu, Yajing Gao, Guangxun Fan, Shengjin Zhou, Zeping Zhou, Fang Liu, LI Yang, Wei Liu, Qifa Zhang, XI Bai, Hai XI, Rui He, Yi Feng, Sizhou Han, Mingzhe |
author_sort | Jiang, Erlie |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10430501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104305012023-08-17 P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS Jiang, Erlie Chen, Shulian Zhang, Xiaoyu Zhai, Weihua Niu, Ting Xu, Yajing Gao, Guangxun Fan, Shengjin Zhou, Zeping Zhou, Fang Liu, LI Yang, Wei Liu, Qifa Zhang, XI Bai, Hai XI, Rui He, Yi Feng, Sizhou Han, Mingzhe Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430501/ http://dx.doi.org/10.1097/01.HS9.0000972080.35265.1c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Jiang, Erlie Chen, Shulian Zhang, Xiaoyu Zhai, Weihua Niu, Ting Xu, Yajing Gao, Guangxun Fan, Shengjin Zhou, Zeping Zhou, Fang Liu, LI Yang, Wei Liu, Qifa Zhang, XI Bai, Hai XI, Rui He, Yi Feng, Sizhou Han, Mingzhe P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS |
title | P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS |
title_full | P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS |
title_fullStr | P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS |
title_full_unstemmed | P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS |
title_short | P1298: THE EFFICACY AND SAFETY OF MODIFIED MELPHALAN AND BUSULFAN-BASED CONDITIONING REGIMEN FOR ALLOGENEIC-HSCT IN REFRACTORY/RELAPSED OR PERSISTENT MRD POSITIVITY AML PATIENTS |
title_sort | p1298: the efficacy and safety of modified melphalan and busulfan-based conditioning regimen for allogeneic-hsct in refractory/relapsed or persistent mrd positivity aml patients |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430501/ http://dx.doi.org/10.1097/01.HS9.0000972080.35265.1c |
work_keys_str_mv | AT jiangerlie p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT chenshulian p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT zhangxiaoyu p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT zhaiweihua p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT niuting p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT xuyajing p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT gaoguangxun p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT fanshengjin p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT zhouzeping p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT zhoufang p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT liuli p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT yangwei p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT liuqifa p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT zhangxi p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT baihai p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT xirui p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT heyi p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT fengsizhou p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients AT hanmingzhe p1298theefficacyandsafetyofmodifiedmelphalanandbusulfanbasedconditioningregimenforallogeneichsctinrefractoryrelapsedorpersistentmrdpositivityamlpatients |